Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis
Authors:
- 5 March 2010
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 24 (4) , 395-402
Abstract
Background Soluble immune receptors (SIRs) have been proposed as biomarkers in patients with atopic dermatitis (AD). However, their clinical applicability in affected children has rarely been studied.Objective To assess the diagnostic usefulness of serum SIRs in childhood AD by correlating the obtained receptor profiles with serological parameters and clinical features such as age, AD phenotype and disease severity.Methods We investigated 100 children with AD. The sCD14, sCD23, sCD25, sCD30, total IgE (tIgE) and eosinophilic cationic protein (ECP) were determined using sera of all children. The clinical phenotype was classified as extrinsic AD (ADe) or intrinsic AD (ADi) by the presence of allergen‐specific IgE antibodies.Results A total of 55 male and 45 female children were recruited. The sCD23, sCD25 and sCD30 serum levels revealed significant age‐dependency. At a mean SCORAD of 40 (range 8–98), none of the evaluated SIRs was correlated to disease severity. In all, 73% of patients suffered from ADe while 27% showed the ADi phenotype. None of the analysed SIRs differed significantly between ADe and ADi patients, while tIgE and ECP levels were elevated in the ADe subgroup.Conclusion The current study provides evidence that sCD23, sCD25 and sCD30 serum levels are highly age‐dependent. Serum concentrations of all investigated SIRs did not significantly correlate with disease severity in children with AD and were not differentially expressed in patients of different AD phenotypes. Therefore, we believe that the studied SIRs cannot be regarded as clinically useful biomarkers for the assessment of childhood AD.Keywords
This publication has 50 references indexed in Scilit:
- Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitisBritish Journal of Dermatology, 2009
- Association between CD14 polymorphisms and serum soluble CD14 levels: Effect of atopy and endotoxin inhalationJournal of Allergy and Clinical Immunology, 2008
- Faecal and serum levels of eosinophil cationic protein in a healthy paediatric populationScandinavian Journal of Clinical and Laboratory Investigation, 2007
- The Relationship Between Serum Levels of Total IgE, IL‐18, IL‐12, IFN‐γ and Disease Severity in Children With Atopic DermatitisMediators of Inflammation, 2006
- Variability of total serum immunoglobulin E levels from birth to the age of 10 years. A prospective evaluation in a large birth cohort (German Multicenter Allergy Study)Clinical & Experimental Allergy, 2005
- Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitisBritish Journal of Dermatology, 1999
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma.Archives of Disease in Childhood, 1996
- Eosinophil cationic protein in serum and nasal washes from wheezing infants and childrenThe Journal of Pediatrics, 1995
- Serum levels of sCD23 and sCD25 in children with asthma and in healthy controls*Allergy, 1994